By The Press Association2012-12-05T10:15:00
A cash pot used to pay for life-extending drugs should not be limited to patients who have cancer, the head of the National Institute for Health and Clinical Excellence has suggested.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud